Stephanie L Servetas1, Dacie R Bridge, D Scott Merrell. 1. Department of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Infection with the Gram-negative, microaerophilic pathogen Helicobacter pylori results in gastric cancer in a subset of infected individuals. As such, H. pylori is the only WHO classified bacterial class I carcinogen. Numerous studies have identified mechanisms by which H. pylori alters host cell signaling pathways to cause disease. The purpose of this review is to highlight recent studies that explore mechanisms associated with induction of gastric cancer. RECENT FINDINGS: Over the last year and a half, new mechanisms contributing to the etiology of H. pylori-associated gastric cancer development have been discovered. In addition to utilizing the oncogenic CagA toxin to alter host cell signaling pathways, H. pylori also induces host DNA damage and alters DNA methylation to perturb downstream signaling. Furthermore, H. pylori activates numerous host cell pathways and proteins that result in epithelial-to-mesenchymal transition and induction of cell survival and proliferation. SUMMARY: Mounting evidence suggests that H. pylori promotes gastric carcinogenesis using a multifactorial approach. Intriguingly, many of the targeted pathways and mechanisms show commonality with diverse forms of cancer.
PURPOSE OF REVIEW: Infection with the Gram-negative, microaerophilic pathogen Helicobacter pylori results in gastric cancer in a subset of infected individuals. As such, H. pylori is the only WHO classified bacterial class I carcinogen. Numerous studies have identified mechanisms by which H. pylori alters host cell signaling pathways to cause disease. The purpose of this review is to highlight recent studies that explore mechanisms associated with induction of gastric cancer. RECENT FINDINGS: Over the last year and a half, new mechanisms contributing to the etiology of H. pylori-associated gastric cancer development have been discovered. In addition to utilizing the oncogenic CagA toxin to alter host cell signaling pathways, H. pylori also induces host DNA damage and alters DNA methylation to perturb downstream signaling. Furthermore, H. pylori activates numerous host cell pathways and proteins that result in epithelial-to-mesenchymal transition and induction of cell survival and proliferation. SUMMARY: Mounting evidence suggests that H. pylori promotes gastric carcinogenesis using a multifactorial approach. Intriguingly, many of the targeted pathways and mechanisms show commonality with diverse forms of cancer.
Authors: Mohammed Soutto; Zheng Chen; Ahmed M Katsha; Judith Romero-Gallo; Uma S Krishna; M Blanca Piazuelo; M Kay Washington; Richard M Peek; Abbes Belkhiri; Wael M El-Rifai Journal: Cancer Date: 2015-09-15 Impact factor: 6.860
Authors: N Murata-Kamiya; Y Kurashima; Y Teishikata; Y Yamahashi; Y Saito; H Higashi; H Aburatani; T Akiyama; R M Peek; T Azuma; M Hatakeyama Journal: Oncogene Date: 2007-01-22 Impact factor: 9.867
Authors: Jae J Kim; Hong Tao; Emilia Carloni; Wai K Leung; David Y Graham; Antonia R Sepulveda Journal: Gastroenterology Date: 2002-08 Impact factor: 22.682
Authors: Barbara G Schneider; Robertino Mera; M Blanca Piazuelo; Juan C Bravo; Jovanny Zabaleta; Alberto G Delgado; Luis E Bravo; Keith T Wilson; Wael El-Rifai; Richard M Peek; Pelayo Correa Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-08-12 Impact factor: 4.254
Authors: Sayed K Elagan; Saad J Almalki; M R Alharthi; Mohamed S Mohamed; Mohamed F El-Badawy Journal: Infect Drug Resist Date: 2021-06-01 Impact factor: 4.003
Authors: Akram Mirzaei; Saeed Mohammadi; Seyed H Ghaffari; Marjan Yaghmaie; Mohammad Vaezi; Kamran Alimoghaddam; Ardeshir Ghavamzadeh Journal: Asian Pac J Cancer Prev Date: 2018-03-27
Authors: Lionel Costa; Sébastien Corre; Valérie Michel; Krysten Le Luel; Julien Fernandes; Jason Ziveri; Gregory Jouvion; Anne Danckaert; Nicolas Mouchet; David Da Silva Barreira; Javier Torres; Margarita Camorlinga; Mario Milco D'Elios; Laurence Fiette; Hilde De Reuse; Marie-Dominique Galibert; Eliette Touati Journal: Gut Date: 2019-12-10 Impact factor: 23.059